Form 4: CareDx COO Kennedy Boosts Stake with RSU Vesting

CareDx Chief Operating Officer Keith Kennedy increased his direct beneficial ownership of common stock through RSU awards and PRSU vesting, partially offset by shares withheld for tax obligations.

Summary

• CareDx, Inc. Chief Operating Officer, Keith Kennedy, reported changes in his beneficial ownership of common stock.
• Kennedy acquired 60,000 shares of common stock through restricted stock units (RSUs) on February 2, 2026, with a vesting schedule commencing April 6, 2027.
• An additional 14,474 shares of common stock were acquired on February 2, 2026, from performance restricted stock units (PRSUs) after the achievement of certain performance criteria was certified.
• 4,644 shares of common stock were disposed of on February 2, 2026, at a price of $20.42 per share, to satisfy tax withholding obligations related to the PRSU vesting.
• Following these transactions, Kennedy's direct beneficial ownership stands at 209,139 shares of CareDx common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices and the achievement of performance targets, which aligns management's interests with long-term company performance. The disposition for tax purposes is a routine event.

Positives

• Keith Kennedy, COO, acquired 60,000 shares via RSU awards, indicating continued long-term incentive alignment with shareholder interests.
• Kennedy earned 14,474 shares from performance restricted stock units (PRSUs), signifying the achievement of specific company performance criteria as certified by the Compensation and Human Capital Committee.

Negatives

• 4,644 shares were disposed of to cover tax withholding obligations, reducing the net increase in beneficial ownership.

Risks

• The vesting of the 60,000 RSU shares is subject to the Reporting Person's continuous employment on each applicable vesting date, posing a risk of forfeiture if employment ceases.

Future Outlook

The 60,000 RSU shares will vest in a structured manner, with one-third vesting on April 6, 2027, and the remaining two-thirds vesting in equal quarterly installments over the subsequent eight quarters, concluding on the third anniversary of April 6, 2027, contingent on continuous employment.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for publicly traded companies, detailing changes in beneficial ownership by insiders. These transactions, particularly those related to compensation like RSU and PRSU vesting, are standard practices for executive incentive programs across various industries, including the diagnostics and healthcare technology sector where CareDx operates.

Comparison to Industry Standards

• This filing reports individual executive compensation and stock transactions, which are not directly comparable to company-level financial results or project outcomes of specific companies. The structure of RSU and PRSU awards, including vesting schedules and performance criteria, is generally aligned with common executive compensation practices in the biotechnology and medical device industries, though specific terms vary by company.

Corporate Governance

Related Party Transactions

• The acquisition of 60,000 RSUs and 14,474 PRSUs by Chief Operating Officer Keith Kennedy represents executive compensation, a transaction between the company and a related party (an officer).

Stakeholder Impact

• Shareholders: Increased insider ownership, particularly through performance-based awards, can signal management's confidence and alignment with shareholder value creation.
• Employees: The vesting of RSUs and PRSUs serves as an incentive for executive retention and performance, potentially influencing overall company morale and strategic execution.

Next Steps

• Continued vesting of 60,000 RSU shares according to the specified schedule, subject to continuous employment.

Key Dates

Keywords

CareDx, CDNA, Form 4, Insider Transaction, Restricted Stock Units, Performance Restricted Stock Units, Executive Compensation, Stock Ownership